The drug was already approved earlier this year for obesity and overweight with related conditions, effectively expanding the company's total addressable market with the addition of an oral alternative to injectable GLP-1 drugs.
parapsilosis : deleting FGR15 ( CPAR2_213110 ) resulted in reduced growth on YNB + glutamate, proline or valine, and the fgr3 ( CPAR2_302310 ) strain could not use urea (Supplementary Fig
Ozempic is still not approved in India, though the semaglutide molecule is available in oral form 13
Theres no special certification required
About this article Cite this article Lee, HG., Rone, J.M., Lee, JH
doi:10.1016/j.wneu.2018.09.070), Dr